Venous ansgiomata: Treatment with sclerosant foam

Annals of Vascular Surgery

Volumn 19, Issue 4, 2005, Pages 457-464

  Pascarella, Luigi ^a   Bergan, John J ^b,c,f   Yamada, Clayton ^c,d   Mekenas, Lisa ^c,e  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c The Vein Institute of La Jolla   (United States)

^d SCRIPPS MEMORIAL HOSPITAL   (United States)

^e Sharp Memorial Sports Medicine Center   (United States)

^f NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SCLEROSING AGENT; MACROGOL DERIVATIVE; POLIDOCANOL;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANGIOMA; ANGIOOSTEOHYPERTROPHY SYNDROME; CLINICAL ARTICLE; CLINICAL FEATURE; COLOR ULTRASOUND FLOWMETRY; CONFERENCE PAPER; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; FEMALE; HUMAN; IMAGE ANALYSIS; LEG PHLEBOGRAPHY; LEG ULCER; MALE; PRIORITY JOURNAL; SCLEROTHERAPY; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; SURGICAL PATIENT; VEIN DISEASE; ARTERIOVENOUS MALFORMATION; ARTICLE; CASE REPORT; DIAGNOSTIC IMAGING; ECHOGRAPHY; HEMANGIOMATOSIS; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING;

ADOLESCENT; ADULT; AGED; ANGIOMATOSIS; ARTERIOVENOUS MALFORMATIONS; DIAGNOSTIC IMAGING; FEMALE; HUMANS; KLIPPEL-TRENAUNAY-WEBER SYNDROME; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POLYETHYLENE GLYCOLS; SCLEROSING SOLUTIONS; ULTRASONOGRAPHY, DOPPLER, DUPLEX;

EID: 23744475703     PISSN: 08905096     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10016-005-4656-z     Document Type: Conference Paper

References (22)

1. Paes E, Vollmar J. Diagnosis and surgical aspects of congenital venous angiodysnplasia in the extremities. Phlebology 1995;10:160-164.
2. Rockman CB, Rosen RJ, Jacobwitz GR, et al. Transcatheter embolization of extremity vascular malformations: the long term success of multiple interventions. Ann Vasc Surg 2003;17:417-423.
3. de Lorimier AA. Sclerotherapy for venous malformations. J Pediatr Surg 1995;30:188-194.
4. Cabrera J, Cabrera J Jr, Garcia-Olmedio MA, Redondo P. Treatment of venous malformations with sclerosant in microfoam form. Arch Dermatol 2003;139:1409-1416.
5. Samuel M, Spitz L. Klippel-Trenaunay syndrome. Clinical features, complications and management in children. Br J Surg 1995;82:757-762.
6. Belov ST. Anatomopathological classification of congenital vascular defects. Semin Vasc Surg 1993;6:219-224.
7. Belov ST. Classification of congenital vascular defects. Int. Angiol. 1990;9:141-146.
8. Hu T-S, Weiss RA. Foam sclerotherapy, a new era. Arch Dermatol 2003;139:1494-1496.
9. Goldman MP, Bergan JJ. Sclerotherapy Treatment of Varicose and Telangiectatic Leg Veins 3rd ed. St. Louis: Mosby, 2001.
10. Conrad P, Malouf GM, Stacey MC. The Australian Polidocanol study: results at 2 years. Dermatol Surg 1995;21:344-346.
11. Cabrera Garrido JR, Cabrera Garcia-Olmedo JR, Garcia-Olmedo Dominguez MA. Elargissement des limites de la sclerotherapie: nouveaux produits sclerosants. Phlebologie 1997;50:181-188.
12. Monfreux A. Traitement sclerosant des troncs sapheniens et leurs collaterales de gros calibres par la methode MUS. Phlebologie 1997;50:351-353.
13. Tessari L. Nouvelle teclinique d'obtention de la sceromousse. Phlebologie 2000;53:129.
14. Frullini A, Cavezzi A. Sclerosing foam in the treatment of varicose veins and telangiectases: history and analysis of safety and complications. Dermatol Surg 2002;28:11-15.
15. Hamel-Desnos C, Desnos P, Ouvry P. Nouveautes therapeutiques dans la prise en charge de la maladie variqueuse: echo-sclerotherapie et mousse. Phlebologie 2003;56: 41-48.
16. Hamel-Desnos C, Desnos P, Wollman J-C, Ouvry P, Mako S, Allaert F-A. Evaluation of the efficacy of Polidocanol in the form of foam compared with liquid form in sclerotherapy of the greater saphenous vein: initial results. Dermatol Surg 2003;29: 1170-1175.
17. Kern P, Ramelet AA, Wutschert R, Bounameaux H, Hayoz D. Single-blind randomized study comparing chromated glycerin, Polidocanol solution, polidocanol foam for treatment of telangiectatic leg veins. Dermatol Surg 2004;30:367-372.
18. Henriet JP. Experience durant 3 annees de la mousse de Polidocanol dans le traitement des varices reticularies et des varicosities. Phlebologie 1995;52:277-282.
19. Rodriguez CJ, Homma S. Patent foramen ovale and stroke. Curr. Treat. Options Cardiovasc Med 2003;5:233-240.
20. Dogan R, Faruk Dogan O, Oc M, Akata D, Gumus B, Balkanci F. A rare vascular malformation, Klippel-Trenaunay syndrome. Report of a case with deep vein agenesis, review of the literature. J Cardiovasc Surg 2003;44:95-100.
21. Eerola I, Mulliken JB, Burrows PE, et al.Capillary malformation- arteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations. Am J Hum Genet 2003;73:1240-1249.
22. Yamaki T, Nozaki M, Sasaki K. Color duplex-guided sclerotherapy for the treatment of venous malformations. Dermatol Surg 2000;26:323-328.